Mr. Weinstein has more than 8 years experience as executive and investor in the life sciences industry. He most recently served as Vice President of Innovation and Development at Abbott Laboratories. Prior to that he was Vice President of Strategy and Innovation at CFR Pharmaceuticals. He has a proven track record of launching over 300 products in the Pharmaceutical industry in Latin America and completing more than 20 licensing deals including Biotech products and Medical Devices.
He currently serves as a Board Member of Convexity Scientific, Via Surgical and Dog Parker. He previously was a board member of BMRC, a biotech research consortium in Chile.
During this challenging time of the COVID-19 pandemic, The health and safety of our patients and our staff is our highest priority at Hygieacare.
Following the guidance from public health authorities to limit the spread of COVID-19 for maintaining a safe environment, We have implemented multiple precautionary measures in the Hygieacare Centers.
We are grateful to the healthcare professionals on the front lines who are fighting to contain the virus and help patients with COVID-19.